Trial Profile
Effect of L-Dihydoxyphenylserine (L-DOPS, Northera) a Central and Peripheral Norepinephrine Agent on Locomotion, Postural Stability (Balance), and Fall Risk Reduction in Parkinson Disease (PD)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2022
Price :
$35
*
At a glance
- Drugs Droxidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 11 Feb 2019 Planned End Date changed from 1 Dec 2017 to 1 Jun 2019.
- 11 Feb 2019 Planned primary completion date changed from 1 Sep 2017 to 1 Jun 2019.
- 11 Feb 2019 Status changed from recruiting to active, no longer recruiting.